Shenzhen Damiti Technology Co., Ltd.

Shenzhen Damiti Technology Co., Ltd. specializes in two primary device types: single-use transcutaneous electrical stimulation electrodes and analgesic transcutaneous electrical nerve stimulation (TENS) systems. These devices are designed to provide pain relief by delivering controlled electrical stimulation through the skin, targeting nerve pathways to alleviate discomfort. The most common product examples fall under these categories, such as the Pohaku series.

The company is based in the United States. While the name suggests a Shenzhen origin, the operational headquarters and manufacturing presence are located within the US market, aligning with regulatory and commercial operations there.

Shenzhen Damiti Technology Co., Ltd.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track and identify medical devices authorized for use in the US, ensuring traceability and compliance with regulatory requirements.

The company’s devices are classified as Class II medical devices. This classification typically applies to products that pose moderate risk and require special controls to ensure safety and effectiveness, such as electrical stimulation devices used for pain management. Class II devices undergo additional scrutiny beyond general controls but do not require pre-market approval like higher-risk Class III devices.